← Evidence map

ArticleLipids in health and disease2021

Empagliflozin protects against atherosclerosis progression by modulating lipid profiles and sympathetic activity.

Yihai Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

32 papers cite it

2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 33436015